22nd Century Group to Present at the Virtual Fall Investor Summit on November 17
November 16 2020 - 9:45AM
22nd Century Group, Inc. (NYSE American: XXII), a leading
plant-based, biotechnology company that is focused on tobacco harm
reduction, very low nicotine content tobacco, and hemp/cannabis
research, announced today that the Company will present and meet
with investors at the Virtual Fall Investor Summit. The conference
is being held virtually November 16 -18, 2020.
22nd Century is scheduled to present on Tuesday,
November 17, 2020 at 4:30 p.m. ET. The live webcast and
presentation will be accessible in the Investors section of 22nd
Century’s website under Events. An archived replay of the webcast
will be available shortly after the live event.
Please visit https://investorsummitgroup.com/ to register for
the conference and schedule one-on-one meeting with 22nd
Century.
About 22nd Century Group, Inc.
22nd Century Group, Inc. (NYSE American: XXII) is a leading
plant biotechnology company focused on technologies that alter the
level of nicotine in tobacco plants and the level of cannabinoids
in hemp/cannabis plants through genetic engineering, gene-editing,
and modern plant breeding. 22nd Century’s primary mission in
tobacco is to reduce the harm caused by smoking through the
Company’s proprietary reduced nicotine content tobacco cigarettes –
containing 95% less nicotine than conventional cigarettes. The
Company’s primary mission in hemp/cannabis is to develop and
commercialize proprietary hemp/cannabis plants with valuable
cannabinoid profiles and desirable agronomic traits.
Learn more at xxiicentury.com, on
Twitter @_xxiicentury and on LinkedIn.
Investor Relations & Media
Contact:Mei KuoDirector, Communications &
Investor Relations22nd Century Group, Inc.(716)
300-1221mkuo@xxiicentury.com
22nd Century (AMEX:XXII)
Historical Stock Chart
From Aug 2024 to Sep 2024
22nd Century (AMEX:XXII)
Historical Stock Chart
From Sep 2023 to Sep 2024